相关实验视频

Updated: Jun 9, 2025

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

探索NOD2风险变体与腹患者肝炎患者的第一次减补事件之间的关系

Henrik Karbannek¹, Matthias C Reichert², Robin Greinert³

¹Department of Internal Medicine IV, Jena University Hospital, Jena, Germany.

Liver international : official journal of the International Association for the Study of the Liver

|October 29, 2024

概括

NOD2 变异增加了补偿性肝硬化患者的第一个失补偿的风险. 这种关联主要与炎的发展有关,突出了这一遗传因素的特定风险组.

科学领域:

胃肠病学胃肠病学
遗传学遗传学是一个
内部医学内部医学

背景情况:

NOD2突变与受损的肠道屏障功能有关.
根据系统性炎症假设,细菌转移是肝硬化脱补偿的关键因素.
NOD2变体在肝硬化的初始失补偿中的作用需要进一步研究.

研究的目的:

调查NOD2变体与补偿性肝硬化患者第一个失补偿的发展之间的关联.
为了确定NOD2变异是否特别影响食道静脉瘤患者的脱补偿风险.

主要方法:

对从2014年至2018年期间查的补偿性肝硬化患者前性收集的数据进行了二次分析.
对患有NOD2变体和没有NOD2变体的患者进行了比较,基于静脉的存在进行了分层分析.
多变量分析以确定脱补偿的独立预测因素.

主要成果:

在360名患者中,70人 (19%) 携带NOD2变体. 总的来说,NOD2状态没有预测第一个脱补偿 (HR 1.75).
在患有静脉动脉的患者中 (n=90),NOD2变异与较高的第一个失补偿发生率 (HR 3.00) 相关,主要是由于 (HR 3.32).
在患有静脉的小组中,MELD得分和NOD2变异独立预测了脱补偿.

结论:

NOD2风险变异与第一个失补偿的发病率增加有关.
这种增加的风险在补偿性肝硬化患者中特别观察到,这些患者也患有静脉动脉.
NOD2 变异可能通过影响该患者亚组中瘤形成的机制导致脱补偿.

关键词:

没有补偿,没有补偿.遗传风险因素是一个遗传风险因素.肝硬化是肝硬化的一种疾病.门高血压门高血压变形体的变形体变形体是什么

更多相关视频

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats

Published on: August 1, 2018

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane

Published on: December 9, 2022

相关概念视频

Esophageal Varices-I: Introduction

Esophageal Varices-I: Introduction

Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...

Esophageal Varices-II: Clinical Features and Management

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

Aortic Regurgitation I: Introduction

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...